Business Description
Emcure Pharmaceuticals Ltd
ISIN : INE168P01015
Compare
Compare
Traded in other countries / regions
544210.India IPO Date
2024-07-10Description
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | 0.85 | |||||
| Interest Coverage | 4.47 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.17 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.7 | |||||
| 3-Year EBITDA Growth Rate | -1.3 | |||||
| 3-Year EPS without NRI Growth Rate | -3.5 | |||||
| 3-Year FCF Growth Rate | 12.2 | |||||
| 3-Year Book Growth Rate | 7.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.89 | |||||
| 9-Day RSI | 34.47 | |||||
| 14-Day RSI | 40.48 | |||||
| 6-1 Month Momentum % | 0.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.57 | |||||
| Quick Ratio | 0.95 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 204.8 | |||||
| Days Sales Outstanding | 93.4 | |||||
| Days Payable | 168.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | -1.09 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.5 | |||||
| Operating Margin % | 13.86 | |||||
| Net Margin % | 7.9 | |||||
| FCF Margin % | 7.83 | |||||
| ROE % | 17.33 | |||||
| ROA % | 7.51 | |||||
| ROIC % | 12.85 | |||||
| 3-Year ROIIC % | -1.17 | |||||
| ROC (Joel Greenblatt) % | 24.26 | |||||
| ROCE % | 22.76 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 43.75 | |||||
| PE Ratio without NRI | 41.83 | |||||
| PS Ratio | 3.45 | |||||
| PB Ratio | 6.22 | |||||
| Price-to-Tangible-Book | 8.23 | |||||
| Price-to-Free-Cash-Flow | 43.87 | |||||
| Price-to-Operating-Cash-Flow | 27.36 | |||||
| EV-to-EBIT | 25.65 | |||||
| EV-to-EBITDA | 18.99 | |||||
| EV-to-Revenue | 3.72 | |||||
| EV-to-FCF | 47.53 | |||||
| Price-to-Graham-Number | 3.91 | |||||
| Price-to-Net-Current-Asset-Value | 57 | |||||
| Earnings Yield (Greenblatt) % | 3.9 | |||||
| FCF Yield % | 2.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Emcure Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 71,798.63 | ||
| EPS (TTM) (₹) | 30.976 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 40.48 | ||
| 14-Day ATR (₹) | 45.254871 | ||
| 20-Day SMA (₹) | 1420.035 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (₹) | 1226.5 - 1577.5 | ||
| Shares Outstanding (Mil) | 189.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Emcure Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Emcure Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Emcure Pharmaceuticals Ltd Frequently Asked Questions
What is Emcure Pharmaceuticals Ltd(BOM:544210)'s stock price today?
The current price of BOM:544210 is ₹1355.35. The 52 week high of BOM:544210 is ₹1577.50 and 52 week low is ₹1226.50.
When is next earnings date of Emcure Pharmaceuticals Ltd(BOM:544210)?
The next earnings date of Emcure Pharmaceuticals Ltd(BOM:544210) is .
Does Emcure Pharmaceuticals Ltd(BOM:544210) pay dividends? If so, how much?
Emcure Pharmaceuticals Ltd(BOM:544210) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers